科研成果详情

题名Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
作者
发表日期2022-06-10
发表期刊FRONTIERS IN ONCOLOGY   影响因子和分区
语种英语
原始文献类型Article
关键词acute myeloid leukemia pyroptosis molecular subtype tumor microenvironment prognosis therapeutic sensitivity
其他关键词GENE-EXPRESSION ; BREAST-CANCER ; STEM-CELLS ; T-CELLS ; IDENTIFICATION ; DISCOVERY ; SURVIVAL
摘要Acute myeloid leukemia (AML) is usually associated with poor prognosis and low complete remission (CR) rate due to individual biological heterogeneity. Pyroptosis is a special form of inflammatory programmed cell death related to the progression, treatment response, and prognosis of multiple tumors. However, the potential connection of pyroptosis-related genes (PRGs) and AML still remains unclear. We described the genetic and transcriptional alterations of PRGs in 151 AML samples and presented a consensus clustering of these patients into two subtypes with distinct immunological and prognostic characteristics. Cluster A, associated with better prognosis, was characterized by relatively lower PRG expression, activated immune cells, higher immune scores in the tumor microenvironment (TME), and downregulation of immunotherapy checkpoints. Subsequently, a PRG score was constructed to predict overall survival (OS) of AML patients by using univariate and multivariate Cox regression analysis, and its immunological characteristics and predictive capability were further validated by 1,054 AML samples in external datasets. Besides an immune-activated status, low-PRG score cohorts exhibited higher chemotherapeutic drug sensitivity and significant positive correlation with the cancer stem cell (CSC) index. Combined with age, clinical French-American-British (FAB) subtypes, and PRG score, we successfully constructed a nomogram to effectively predict the 1-/3-/5-year survival rate of AML patients, and the predictive capability was further validated in multiple external datasets with a high area under the curve (AUC) value. The various transcriptomic analysis helps us screen significant pyroptosis-related signatures of AML and provide a new clinical application of PRG scores in predicting the prognosis and benefits of treatment for AML patients.
资助项目General Scientific Projects of Zhejiang Education Department [Y202147905]
出版者FRONTIERS MEDIA SA
出版地LAUSANNE
ISSN2234-943X
卷号12页码:898236
DOI10.3389/fonc.2022.898236
页数17
WOS类目Oncology
WOS研究方向Oncology
WOS记录号WOS:000815786800001
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
PubMed ID35756629
SCOPUSEID2-s2.0-85133463814
通讯作者地址[Yu, Kang]Department of Hematology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China ; [Jin, Zhenlin]Department of Hematology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China
Scopus学科分类Oncology;Cancer Research
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/154529
专题检验医学院(生命科学学院、生物学实验教学中心)
附属第一医院_血液内科
通讯作者Yu, Kang; Jin, Zhenlin
作者单位
1.Department of Laboratory Medicine,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China;
2.Department of Hematology,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China;
3.Department of Operating Room,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China
第一作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
通讯作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
第一作者的第一单位附属第一医院
推荐引用方式
GB/T 7714
Pan, Jingjing,Jiang, Yinyan,Li, Changhong,et al. Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia[J]. FRONTIERS IN ONCOLOGY,2022,12:898236.
APA Pan, Jingjing, Jiang, Yinyan, Li, Changhong, Jin, Ting, Yu, Kang, & Jin, Zhenlin. (2022). Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia. FRONTIERS IN ONCOLOGY, 12, 898236.
MLA Pan, Jingjing,et al."Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia".FRONTIERS IN ONCOLOGY 12(2022):898236.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Pan, Jingjing]的文章
[Jiang, Yinyan]的文章
[Li, Changhong]的文章
百度学术
百度学术中相似的文章
[Pan, Jingjing]的文章
[Jiang, Yinyan]的文章
[Li, Changhong]的文章
必应学术
必应学术中相似的文章
[Pan, Jingjing]的文章
[Jiang, Yinyan]的文章
[Li, Changhong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。